Production (Stage)
Adagio Medical Holdings, Inc.
ADGM
$1.19
$0.043.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 75.64% | 351.22% | 109.92% | -56.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 75.64% | 351.22% | 109.92% | -56.67% |
| Cost of Revenue | -53.32% | 355.99% | 125.69% | 70.07% | 70.44% |
| Gross Profit | 50.97% | -441.41% | -82.08% | -52.86% | -100.00% |
| SG&A Expenses | -27.85% | 22.62% | 74.72% | 54.05% | 202.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.33% | 66.14% | 18.57% | -1.17% | 31.68% |
| Operating Income | 16.09% | -66.00% | -17.07% | 3.13% | -32.48% |
| Income Before Tax | 3.80% | -565.46% | 56.98% | 41.21% | 13.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.80% | -565.46% | 56.98% | 41.21% | 13.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.80% | -565.46% | 56.98% | 41.21% | 13.56% |
| EBIT | 16.09% | -66.00% | -17.07% | 3.13% | -32.48% |
| EBITDA | 16.02% | -62.10% | -14.64% | 4.93% | -29.94% |
| EPS Basic | 95.12% | 66.95% | 96.66% | 48.06% | 16.07% |
| Normalized Basic EPS | 95.12% | 95.30% | 96.66% | 48.06% | 16.07% |
| EPS Diluted | 95.00% | 66.95% | 96.66% | 48.06% | 16.07% |
| Normalized Diluted EPS | 95.12% | 95.30% | 96.66% | 48.06% | 16.07% |
| Average Basic Shares Outstanding | 1,871.47% | 1,913.29% | 1,187.89% | 13.19% | 2.98% |
| Average Diluted Shares Outstanding | 1,871.47% | 1,913.29% | 1,187.89% | 13.19% | 2.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |